Seed Round - Prodesse

Seed Round - Prodesse

Investment Firm

Overview

Prodesse develops molecular diagnostic reagents for a variety of infectious disease applications.

Announced Date

Jan 01, 2002

Funding Type

Seed

Highlights

Location

United States, North America

Social

N/A

Investor Lead

Thomas Shannon

Thomas Shannon

Thomas Shannon is a seed firm.

Participant Investors

5

Investor Name
Participant InvestorSilicon Pastures
Participant InvestorAndrew Shannon
Participant InvestorWisconsin Investment Partners
Participant InvestorJeff Rusinow
Participant InvestorThomas Shannon

Round Details and Background

Prodesse raised $1500000 on 2002-01-01 in Seed Round

Prodesse develops molecular diagnostic reagents for a variety of infectious disease applications.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2002
Seed Round - Prodesse
5-1.5M

Recent Activity

There is no recent news or activity for this profile.